JMPWA
IMMU

JP Morgan Private Wealth Advisors’s Immunomedics Inc IMMU Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,644
Closed -$2.27M – 1758
2020
Q3 		$2.27M Sell
26,644
-6,609
-20% -$334K 0.01% 617
2020
Q2 		$1.18M Sell
33,253
-1,922
-5% -$56.2K 0.01% 753
2020
Q1 		$474K Buy
35,175
+4,260
+14% +$71.7K ﹤0.01% 951
2019
Q4 		$654K Buy
30,915
+14,225
+85% +$251K ﹤0.01% 946
2019
Q3 		$221K Buy
16,690
+5,817
+53% +$85.5K ﹤0.01% 1304
2019
Q2 		$151K Buy
+10,873
New +$164K ﹤0.01% 1317
2015
Q2 		– Sell
-20,000
Closed -$77K – 1166
2015
Q1 		$77K Hold
20,000
– – ﹤0.01% 1100
2014
Q4 		$96K Sell
20,000
-5,000
-20% -$19.8K ﹤0.01% 1049
2014
Q3 		$93K Buy
+25,000
New +$84.5K ﹤0.01% 1039

JP Morgan Private Wealth Advisors's IMMU Position: Q4 2020 in Review

JP Morgan Private Wealth Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 26,644 shares — an estimated $2.27M sold.

JP Morgan Private Wealth Advisors first reported a position in IMMU in Q3 2014 and held it in 9 quarters. The position peaked at $2.27M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • JP Morgan Private Wealth Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 26,644 Immunomedics Inc shares in Q4 2020, an estimated $2.27M.
  • JP Morgan Private Wealth Advisors first reported a position in Immunomedics Inc in Q3 2014 and held it in 9 quarters.
  • JP Morgan Private Wealth Advisors's Immunomedics Inc position peaked at $2.27M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.